Dr Brian ShentonAssociate Lecturer
Email: brian.shenton@ncl.ac.uk Telephone: +44 (0) 191 222 8441 Address: 3rd Floor, William Leech Building
Sultan J, Griffin SM, Di Franco F, Kirby JA, Shenton BK, Seal CJ, Davis P, Viswanath YKS, Preston SR, Hayes N. Randomized clinical trial of omega-3 fatty acid-supplementedenteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery .
British Journal of Surgery 2012, 99 (3), 305-447.
Leung E, Shenton BK, Green K, Gould K, Jackson G, Talbot D. Changes in EBV gene load in renal transplant recipients .
Transplantation Proceedings 2003, 35 (2), 794-795.
Smout JD, Mikhailidis DP, Shenton BK, Stansby G. Combination antiplatelet therapy in patients with peripheral vascular bypass grafts: a randomized controlled trial .
In: British Journal of Surgery: Annual Meeting of the Association of Surgeons of Great Britain and Ireland . 2003, Manchester, UK: John Wiley & Sons Ltd.
Talbot D, Shenton BK, Buckley PE, Gok MA. Experiences learned in the successful establishment of a nonheart beating donor program for renal transplantation .
Journal of Urology 2003, 170 (4), 1088-1092.
Bell A, Talbot D, Carter V, Manas D, Shenton B. [Meeting abstract] Comparison of panel reactive antibody methodologies .
Cytometry 2002, (s11), 110-111.
Wigfield CH, Golledge HDR, Shenton BK, Kirby JA, Dark JH. Ameliorated reperfusion injury in lung transplantation after reduction of brain death induced inflammatory graft damage in the donor .
Journal of Heart and Lung Transplantation 2002, 21 (1), 57.
Gok MA, Shenton BK, Peaston R, Cornell C, Mathers M, Robertson H, Talbot D, Mantle D. Comparison of glutathione S-transferase and alanyl aminopeptidase as viability markers in a porcine NHBD model .
Comparative Clinical Pathology 2002, 11 (3), 140-147.
Gok MA, Shenton BK, Peaston R, Cornell C, Robertson H, Mathers M, Aitchison JD, Dark JH, Mantle D, Talbot D. Improving the quality of kidneys from non-heartbeating donors, using streptokinase: An animal model .
Transplantation 2002, 73 (12), 1869-1874.
Leung E, Shenton BK, Jackson G, Gould FK, Yap C, Talbot D. Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood .
Journal of Immunological Methods 2002, 270 (2), 259-267.
Gok MA, Shenton BK, Peaston R, Cornell C, Gicquel HJ, Aitchison D, Mantle D, Dark J, Talbot D. Use of streptokinase in a non-heart-beating donor animal model .
In: Transplantation Proceedings: 2nd International Congress on Immunosuppression . 2002, San Diego, California, USA: Elsevier Inc.
Hodgson DR, Clayton SJ, Girdler F, Brotherick I, Shenton B, Browell D, Stuart M, Fox JC, Ceuppens P, Foy CA, Whitcombe D, Gibson NJ. ARMS (TM) allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast .
Clinical Chemistry 2001, 47 (4), 774-778.
Gerstenkorn C, Robertson H, Bell A, Shenton B, Talbot D. CMV infection as a contributory factor for renal allograft injury and loss .
Transplantation Proceedings 2001, 33 (4), 2461–2462.
Chishti AD, Dark JH, Kesteven P, Powell H, Snowden C, Shenton BK, Kirby JA, Baudouin SV. Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass .
Journal of Thoracic and Cardiovascular Surgery 2001, 122 (6), 1162-1166.
Shenton BK, Manas D, Dark JH, Talbot D, Clark KR, Bell A. Immune monitoring of anti-thymocyte globulin (ATG) treatment in transplant patients .
Clinical and Applied Immunology Reviews 2001, 1 (6), 347-371.
Hanson JM, Broweil DA, Cunliffe WJ, Varma J, Allen A, Hemming D, Shenton BK, Young JR, Higgs MJ, Brotherick I, Pearson JP. MUC1 expression in primary breast cancer: The effect of tamoxifen treatment .
Breast Cancer Research and Treatment 2001, 67 (3), 215-222.
Gok MA, Shenton BK, Strong A, Buckley PE, Mohamed MAS, Talbot D. Pump upgrade for machine perfusion at the Freeman Hospital in Newcastle .
Transplant International 2001, 14 (3), 207-207.
Bradford IMJ, Bell AE, Shenton BK, Varma JS, Plusa SM. Regulation of chemotaxis by alpha chemokines and their receptors is abnormal in ulcerative colitis .
In: British Society of Gastroenterology Annual Meeting . 2001, Glasgow, UK: BMJ Group.
Navarro A, Brotherick I, Cunliffe WJ, Higgs MJ, Browell DA, Young JR, Girdler F, Pedersen RO, Shenton BK. The variation in expression of cytokeratin phenotypes in primary breast cancer .
In: Breast Cancer Research and Treatment: 24th Annual San Antonio, Breast Cancer Symposium . 2001, San Antonio, Texas, USA: Springer.
Girdler F, Browell DA, Cunliffe WJ, Shenton BK, Hemming JD, Scorer P, Young JR, Brotherick I. Use of the monoclonal antibody DAKO-ERβ (8D5-1) to measure oestrogen receptor beta in breast cancer cells .
Cytometry 2001, 45 (1), 65-72.
Gok MA, Shenton BK, Cornell C, Peaston R, Aitchison JD, Dark JH, Talbot D, Mantle D. Viability assessment of non-heart beating donor kidneys: Alanine-aminopeptidase and glutathione s-transferase: An animal model .
In: ECCP 2001: The Fifth European Comparative Clinical Pathology Conference . 2001, Edinburgh, Scotland: Springer.
Shenton BK, Bell A. Clinical value of monitoring efficacy of ATG therapy in transplant patients .
In: 15th Annual Meeting, Clinical Applications of Cytometry . 2000, Austin, Texas: John Wiley & Sons.
Barnett DD, Storie I, Granger V, Whitby L, Reilly JT, Brough S, Garner S, Lawry J, Richards S, Bell AE, Shenton BK. Standardization of lymphocyte antibody binding capacity - a multi-centre study .
Clinical and Laboratory Haematology 2000, 22 (2), 89-96.
Watson DS, Brotherick I, Shenton BK, Wilson RG, Angus B, Varma JS, Campbell FC. Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer .
Oncology 1999, 56 (1), 66-72.
